211 related articles for article (PubMed ID: 11051238)
21. A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.
Türeci O; Sahin U; Koslowski M; Buss B; Bell C; Ballweber P; Zwick C; Eberle T; Zuber M; Villena-Heinsen C; Seitz G; Pfreundschuh M
Oncogene; 2002 May; 21(24):3879-88. PubMed ID: 12032826
[TBL] [Abstract][Full Text] [Related]
22. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
23. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
[TBL] [Abstract][Full Text] [Related]
24. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
[TBL] [Abstract][Full Text] [Related]
25. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.
Söling A; Schurr P; Berthold F
Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332
[TBL] [Abstract][Full Text] [Related]
27. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
28. Expression of cancer-testis genes in brain tumors.
Lee MH; Son EI; Kim E; Kim IS; Yim MB; Kim SP
J Korean Neurosurg Soc; 2008 Apr; 43(4):190-3. PubMed ID: 19096642
[TBL] [Abstract][Full Text] [Related]
29. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
Cancer Res; 2005 Mar; 65(6):2207-15. PubMed ID: 15781633
[TBL] [Abstract][Full Text] [Related]
30. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
[TBL] [Abstract][Full Text] [Related]
31. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
Bodey B; Bodey V; Siegel SE
In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
[TBL] [Abstract][Full Text] [Related]
32. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
33. Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.
Chen YT; Iseli C; Venditti CA; Old LJ; Simpson AJ; Jongeneel CV
Genes Chromosomes Cancer; 2006 Apr; 45(4):392-400. PubMed ID: 16382448
[TBL] [Abstract][Full Text] [Related]
34. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
37. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
38. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
Kienstra MA; Neel HB; Strome SE; Roche P
Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.
Ries J; Schultze-Mosgau S; Neukam F; Diebel E; Wiltfang J
Int J Oncol; 2005 Mar; 26(3):817-24. PubMed ID: 15703841
[TBL] [Abstract][Full Text] [Related]
40. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
Sato S; Noguchi Y; Wada H; Fujita S; Nakamura S; Tanaka R; Nakada T; Hasegawa K; Nakagawa K; Koizumi F; Ono T; Nouso K; Jungbluth A; Chen YT; Old LJ; Shiratori Y; Nakayama E
Int J Oncol; 2005 Jan; 26(1):57-63. PubMed ID: 15586225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
